Syringes Market
Buy Now Request Sample Explore
Home › Report Store › Life Sciences  › Syringes Market

Syringes Market Outlook: Size, Share, Trends, Growth Analysis, Competitive Landscape & Forecast, 2026-2033

The Syringes Market size was valued at US$ 21.08 billion in 2025 and is projected to reach US$ 43.65 billion by 2033, growing at a CAGR of 9.53% during 2026–2033, driven by the adoption of injectable medicines, rising demand for chronic disease treatments, safety-product demand, and expanding opportunities for biologics delivery.

Report Coverage
  • Product Type: Conventional Syringes, Safety Syringes
  • Volume Capacity: Up to 1 ml, 1 ml-5 ml, 6 ml-10 ml, 11 ml-20 ml, and Above 20 ml
  • Material: Plastic Syringes, Glass Syringes
  • Usage: Disposable Syringes, Reusable Syringes
  • End User: Hospitals & ASCs, Clinics, Clinical Laboratories, Pharmaceutical & Biotechnology Companies, Others
US$ 21.08 Bn Market size in 2025
US$ 43.65 Bn Market Size by 2033
9.53% CAGR, 2026 - 2033
2026-2033 Forecast Period
AI Overview

Syringes Market Summary

  • North America Region: North America holds a 34%–37% share in 2025, growing at a CAGR of 8.8%–9.4% due to advanced healthcare infrastructure, high injectable therapy adoption, safety regulations, and pharmaceutical innovation. The US market analysis indicates a CAGR of 8.9%–9.3% from 2026–2033, supported by hospital procurement, biologics manufacturing, and demand for prefilled systems.
  • Fastest Growing Region: Asia Pacific holds a 27%–30% share in 2025, expanding at a CAGR of 10.8%–11.6% through healthcare infrastructure development, vaccination initiatives, domestic manufacturing expansion, and increasing access to injectable therapies across emerging economies.
  • Leading Segment: Safety Syringes account for a 52%–55% share in 2025, growing at a CAGR of 10.1%–10.8% due to needlestick prevention requirements, healthcare worker protection measures, and increasing adoption across hospitals and clinics.
  • High Growth Segment: Glass Syringes are advancing at a CAGR of 10.5%–11.2% during 2026–2033, supported by biologics, prefilled drug delivery platforms, and pharmaceutical compatibility requirements for sensitive formulations.
  • Key Market Opportunity: Growth opportunities are emerging from biologics, self-injection systems, vaccine delivery, and advanced manufacturing technologies that improve safety, accuracy, and pharmaceutical compatibility across healthcare applications.
  • Major Market Players: Becton, Dickinson and Company, Terumo Corporation, B. Braun SE, Nipro Corporation, Cardinal Health, Inc., Gerresheimer AG, SCHOTT Pharma AG, Hindustan Syringes and Medical Devices Ltd., Fresenius SE & Co. KGaA, Medtronic plc.
Strategic Insights

Syringes Market: Strategic Insights

Syringes Market Strategic Framework
FREE PDF
Request your free sample
Request free sample
Stakeholder View

Key Takeaways

  • The market ecosystem is becoming increasingly integrated, connecting raw material suppliers, syringe manufacturers, sterilization providers, pharmaceutical companies, and healthcare distributors to improve reliability and production efficiency.
  • Demand growth is shifting toward safety syringes, prefilled systems, and specialized delivery formats as healthcare providers seek improved administration accuracy and reduced occupational risks.
  • Manufacturing innovation is focused on advanced polymers, high-performance glass systems, automated inspection technologies, and compatibility improvements for complex injectable formulations.
  • Asia Pacific offers strong expansion potential due to healthcare investment, pharmaceutical manufacturing strength, and rising treatment accessibility in China, India, and Southeast Asia.
  • Industry consolidation is increasing through capacity expansions, strategic collaborations, and technology investments aimed at strengthening positions in injectable drug delivery markets.
Geographic Outlook

Syringes Market Regional Highlights

North America Syringes Market

North America accounted for 34%–37% of the market in 2025 and is projected to expand at a CAGR of 8.8%–9.4% between 2026–2033. Strong healthcare infrastructure, advanced pharmaceutical development, and regulatory focus on injection safety support regional leadership. The region continues to see significant demand from hospitals, biotechnology companies, and specialty drug manufacturers. The Syringes Market share reflects mature healthcare systems and strong adoption of advanced delivery technologies.

  • Safety syringe adoption is increasing due to workplace protection standards and healthcare provider focus on reducing needlestick incidents.
  • Pharmaceutical companies are expanding partnerships for prefilled syringe manufacturing supporting biologics and specialty medicines.
  • Automation investments are improving manufacturing consistency, quality control, and production scalability across regional facilities.
  • Canada contributes through healthcare modernization programs and increasing demand for injectable treatments.

US Syringes Market

The US market accounted for 29%–32% of the market share in 2025 and is expected to grow at a CAGR of 8.9%–9.3% during 2026–2033. The country remains a major contributor due to advanced medical infrastructure, pharmaceutical innovation, and widespread adoption of injectable therapies. Strong demand from hospitals, clinics, and biotechnology companies supports continued market expansion.

  • Hospitals increasingly replace conventional products with safety-focused solutions to improve healthcare worker protection.
  • Biopharmaceutical research growth supports demand for premium glass and prefilled syringe technologies.
  • Domestic production investments strengthen supply chain resilience for critical medical devices.

Europe Syringes Market

Europe held a 25%–28% share in 2025 and is estimated to grow at a CAGR of 8.5%–9.2% from 2026 to 2033. Germany, France, and the United Kingdom represent major markets, supported by established pharmaceutical industries and healthcare systems. Germany demonstrates strong Syringes Market growth through medical device manufacturing capabilities, while European regulations continue encouraging safer injection practices.

  • Germany benefits from pharmaceutical manufacturing expertise and advanced medical device production capabilities.
  • France supports adoption through healthcare programs and expanding injectable treatment requirements.
  • The United Kingdom drives demand through healthcare innovation and clinical research activities.
  • European sustainability initiatives influence material selection and manufacturing strategies.

Asia Pacific Syringes Market

Asia Pacific accounted for 27%–30% of the market in 2025 and is projected to expand at a CAGR of 10.8%–11.6% during 2026–2033. The region represents the fastest-growing opportunity due to expanding healthcare access, pharmaceutical manufacturing capabilities, and government-led immunization initiatives. China, India, and Japan remain key contributors, while Southeast Asian countries are improving their healthcare infrastructure and increasing the adoption of injectable treatments.

  • China strengthens regional demand through large-scale pharmaceutical production, medical device manufacturing, and healthcare infrastructure investments.
  • India supports expansion through domestic syringe production capabilities, increasing healthcare accessibility, and growing pharmaceutical exports.
  • Japan drives premium product adoption through advanced biotechnology applications and demand for high-quality delivery systems.
  • Southeast Asian countries experience rising utilization due to hospital expansion, vaccination programs, and improved clinical services.

Rest of World Syringes Market

The rest of the world represented a 9%–12% share in 2025 and is forecast to grow at a CAGR of 9.5%–10.3% between 2026 and 2033. South and Central America are supported by healthcare expansion and vaccination initiatives, while the Middle East and Africa benefit from hospital investments and improved access to healthcare. Brazil, Mexico, Gulf countries, and South Africa represent important demand centers.

  • Brazil contributes through healthcare network expansion, pharmaceutical development, and increasing demand for injectable therapies.
  • Mexico benefits from medical manufacturing growth and integration with international healthcare supply chains.
  • Gulf countries invest in advanced healthcare facilities, supporting demand for specialized injection products.
  • South Africa represents a key African market through healthcare modernization and disease management programs.
Global Market Geography
FREE PDF
Request your free sample
Request free sample
Segment Analysis

Syringes Market Segmentation

Product Type

Product Type segmentation includes Conventional Syringes and Safety Syringes. Safety Syringes represent the leading category, with a 52%–55% share in 2025, and are projected to expand at a 10.1%–10.8% CAGR in the Syringes Market Forecasts. Increasing healthcare worker safety requirements, regulatory compliance, and infection prevention initiatives are accelerating adoption. Conventional products remain relevant across cost-sensitive healthcare applications, while safety-focused innovations influence long-term product development strategies.

  • Conventional Syringes: Conventional syringes maintain demand across routine injections, laboratory procedures, and applications where affordability and established availability influence purchasing decisions.
  • Safety Syringes: Safety syringes gain adoption through integrated protection mechanisms, reducing accidental injuries and supporting healthcare facility compliance with occupational safety requirements.

By Volume Capacity

Volume Capacity segmentation includes Up to 1 mL, 1 mL – 5 mL, 6 mL – 10 mL, 11 mL – 20 mL, and Above 20 mL. Demand patterns vary according to therapeutic requirements, medication dosage, and clinical applications. The increasing use of precision medicines and specialized therapies is driving demand across multiple capacity categories. The Syringes Market scope continues to broaden through applications requiring accurate delivery and efficient medication administration.

  • Up to 1 mL: Low-volume syringes support insulin administration, vaccines, and specialty medicines requiring precise dosing and minimal drug wastage.
  • 1 mL – 5 mL: This category serves broad healthcare applications, including routine injections, outpatient treatments, and pharmaceutical administration procedures.
  • 6 mL – 10 mL: Medium-capacity syringes support clinical procedures, fluid administration, and diagnostic applications requiring moderate volume delivery.
  • 11 mL – 20 mL: Larger syringes address specialized medical procedures, irrigation requirements, and applications requiring increased medication or fluid capacity.
  • Above 20 mL: High-capacity syringes serve specialized healthcare uses where larger-volume administration requirements influence product selection.

Material

Material segmentation includes Plastic Syringes and Glass Syringes: pharmaceutical compatibility, production efficiency, storage requirements, and application-specific performance influence material selection. Plastic syringes remain widely used in disposable healthcare applications due to scalable manufacturing and cost advantages. Glass syringes are increasingly preferred for biologics and sensitive formulations that require chemical stability. The Syringes Market trends indicate continued material innovation focused on safety, reliability, and pharmaceutical performance.

  • Plastic Syringes: Plastic syringes dominate disposable applications due to lightweight construction, cost efficiency, manufacturing scalability, and broad healthcare adoption.
  • Glass Syringes: Glass syringes support biologics, prefilled delivery systems, and sensitive pharmaceutical applications requiring strong stability and low interaction properties.

Usage

Usage segmentation includes Disposable Syringes and Reusable Syringes. Disposable products are the dominant category due to infection-prevention priorities, healthcare safety standards, and convenience in clinical workflows. Reusable syringes remain relevant for use in selected healthcare environments where sterilization systems are in place. Increasing emphasis on contamination control and operational efficiency continues to influence purchasing decisions across hospitals, clinics, and specialized healthcare facilities.

  • Disposable Syringes: Disposable syringes support widespread clinical use through single-use practices, reducing contamination risks and improving healthcare workflow efficiency.
  • Reusable Syringes: Reusable syringes serve specialized applications where sterilization capabilities, sustainability objectives, and controlled usage environments influence adoption.

End User

End User segmentation covers Hospitals & ASCs, Clinics, Clinical Laboratories, Pharmaceutical & Biotechnology Companies, and Others. Healthcare facilities represent the largest consumption base due to extensive injection requirements, while pharmaceutical and biotechnology companies influence demand through injectable drug development. Growing biologics pipelines, vaccine production, and specialty therapies are expanding procurement opportunities across end-user categories.

  • Hospitals & ASCs: Hospitals and ambulatory surgical centers represent major users due to high procedure volumes and extensive requirements for injectable treatments.
  • Clinics: Clinics contribute demand through outpatient procedures, vaccination services, and chronic disease management requiring regular medication administration.
  • Clinical Laboratories: Clinical laboratories utilize syringes for sample collection, diagnostic workflows, and research applications requiring accurate handling.
  • Pharmaceutical & Biotechnology Companies: Pharmaceutical and biotechnology companies drive demand through biologics, vaccines, injectable formulations, and prefilled syringe development.
Market Forces

Syringes Market Dynamics

Key Market Drivers

Increasing Adoption of Safety-Engineered Injection Systems

Safety regulations and healthcare worker protection initiatives are accelerating the transition from conventional syringes to safety-focused alternatives. The demand for syringes with features like automatic shields is high because needlestick prevention rules within healthcare systems in developed nations have pushed hospitals into investing in such medical devices. As a result, the manufacturers are producing syringes that not only protect health workers but are also easy to use. In addition, increased knowledge among healthcare professionals and institutional policies are generating demand for these syringes.

Growth of Injectable Biologics and Specialty Medicines

The expanding pipeline of biologics, vaccines, and specialty injectable medicines is increasing demand for advanced syringe formats compatible with sensitive pharmaceutical formulations. The use of biologics requires careful handling, contamination prevention, and proper packaging. Companies that produce pharmaceuticals are increasingly working together with syringe manufacturers to provide pre-filled systems and good-quality glass packaging technology. The collaboration creates room for suppliers capable of meeting demanding quality specifications.

Expansion of Healthcare Infrastructure in Emerging Markets

Healthcare investment across developing economies is improving access to injectable treatments and increasing medical device consumption. Asian Pacific nations, Latin American nations, and Middle Eastern nations are increasing hospital infrastructure, immunization programs, and drug manufacturing facilities. These efforts are helping boost the demand for disposable syringes and injection systems. Healthcare programs and private-sector involvement are helping market development by ensuring the availability of treatments and establishing reliable supply chains.

Key Market Opportunities

Expansion of Prefilled Syringe Applications

Prefilled syringe adoption is increasing as pharmaceutical companies prioritize improved dosing accuracy, reduced preparation time, and enhanced patient convenience. The growth of injectable biologicals and specialty drugs is driving the interest in integrated drug delivery systems. Pharmaceutical firms are working on next-generation filling solutions and collaborating with drug firms to cater to complex formulations. There are many areas where there are great prospects like precision drug delivery in autoimmune, vaccine, and chronic care treatments.

Investment in Smart and Connected Delivery Technologies

Advances in digital healthcare are creating opportunities for syringe systems integrated with monitoring and administration technologies. Linked delivery systems could be used for tracking medications, improving adherence, and managing health care data. Though the adoption of such solutions is still in its infancy, the increasing interest in personalized medicine and remote health care concepts provides some incentive to develop innovative solutions. The investment in technology-based injectable systems could provide some competitive advantage.

Manufacturing Expansion in Emerging Economies

Regional manufacturing investments are creating opportunities to improve supply chain resilience and reduce dependence on imported medical devices. Domestic production capabilities for important healthcare products are being encouraged by governments and healthcare agencies. Emerging nations with well-established pharmaceutical industries are receiving investment in syringe production, sterilization, and packaging operations. This helps promote local access to healthcare and provides opportunities for manufacturers with efficient production locations.

Market Restraints and Challenges

Raw Material Price Volatility and Supply Chain Pressure

Factor: Fluctuations in prices of medical-grade polymers, glass, and specialized components can increase manufacturing costs and affect production planning.

Impact: Manufacturers can face margin pressures and will have to resort to diversification of their supply chains in order to keep prices stable. The global disruptions in logistics, energy, and materials can affect production schedules. Those companies that have vertical integration along with diversification in suppliers can better cope with fluctuating costs without compromising on quality and regulation.

Stringent Regulatory Requirements and Quality Compliance

Factor: Medical device regulations require extensive validation, documentation, sterilization controls, and quality testing before syringe products reach healthcare markets.

Impact: Compliance issues may delay product development and raise costs. Differences in regulations in various regions may add further complication for those firms working in an international market. Companies should continually improve their quality management systems and manufacturing processes to compete effectively in global health markets.

Company Analysis

Competitive Landscape

The Syringes Market analysis highlights a competitive environment shaped by manufacturing scale, product innovation, regulatory capabilities, and partnerships with pharmaceutical companies. Leading companies are focusing on safety-engineered products, prefilled-syringe technologies, sterile manufacturing capabilities, and geographic expansion to strengthen their market positions. The competitive landscape includes global medical device manufacturers and specialized injectable delivery solution providers.

Company Name

Overview

Products and Services relevant to this market

Becton, Dickinson and Company

Global medical technology company providing advanced injection and medication delivery solutions.

Safety syringes, conventional syringes, injection devices, and medication delivery systems.

Terumo Corporation

Japanese healthcare company specializing in medical devices and blood management technologies.

General-purpose syringes, safety products, injection systems, and pharmaceutical delivery solutions.

B. Braun SE

Healthcare technology company focused on infusion therapy and medical products.

Disposable syringes, safety injection products, and clinical administration systems.

Nipro Corporation

Medical device manufacturer offering healthcare products worldwide.

Plastic syringes, glass syringes, injection products, and pharmaceutical packaging solutions.

Cardinal Health, Inc.

Healthcare services and medical product distribution company.

Disposable syringes, safety devices, and healthcare supply solutions.

Gerresheimer AG

Pharmaceutical packaging and drug delivery solutions provider.

Glass syringes, prefillable syringe systems, and pharmaceutical containment products.

SCHOTT Pharma AG

Specialty pharmaceutical packaging company serving the injectable medicines market.

Prefillable glass syringes, polymer syringes, and drug delivery components.

Hindustan Syringes and Medical Devices Ltd.

Indian medical device manufacturer specializing in injection products.

Disposable syringes, auto-disable syringes, and safety injection devices.

Fresenius SE & Co. KGaA

Global healthcare company providing clinical and pharmaceutical solutions.

Medical consumables, injectable therapy support products, and healthcare systems.

Medtronic plc

Medical technology company developing healthcare devices and therapeutic solutions.

Injection-related technologies, drug delivery solutions, and medical devices.
Industry Activity

Recent Developments

March 2026

Gerresheimer launched Gx InMonit, a novel smart add‑on device designed to enhance patient support and engagement for autoinjector‑based home treatments.

January 2026

Terumo Medical Corporation launched the SurTract Safety Syringe in the U.S., featuring passive automatic needle retraction technology that reduces needlestick injury risks for healthcare professionals while expanding its portfolio of safety-engineered syringe solutions.

January 2026

Becton, Dickinson and Company (BD) and Ypsomed expanded their collaboration to develop a 5.5 mL BD Neopak XtraFlow glass prefillable syringe compatible with the YpsoMate 5.5 autoinjector platform. The solution is designed to support the delivery of high-volume, high-viscosity biologics for chronic disease treatment.

January 2026

West Pharmaceutical Services launched the Synchrony S1 prefillable syringe (PFS) system at Pharmapack Europe 2026. The platform offers multiple syringe configurations to simplify biologic drug delivery, support combination product development, and meet growing demand for self-administration therapies.

Trust & Transparency

Research Methodology

The market analysis combines proprietary research with secondary data from government agencies, company disclosures, regulatory filings, industry databases and expert interviews. Market estimates are validated through data triangulation, cross-market benchmarking and analyst review.

View Full Research Methodology
Questions Answered

Frequently Asked Questions

Where can stakeholders find detailed market insights?

The Syringes Market Report provides a detailed analysis of segmentation, competitive positioning, regional trends, growth factors, challenges, and future industry opportunities.

What role does regional manufacturing play in supply security?

Regional manufacturing improves supply resilience by reducing dependency on international supply chains and supporting faster access to essential medical devices during healthcare demand fluctuations.

How are pharmaceutical companies impacting syringe innovation?

Pharmaceutical companies are driving innovation through demand for prefilled systems, biocompatible materials, sterile packaging solutions, and customized delivery platforms for complex injectable medicines.

Which product category is gaining stronger adoption among healthcare providers?

Safety syringes are gaining wider adoption due to regulatory attention to reducing needlestick injuries and improving workplace protection standards in healthcare settings.

What factors are influencing the demand for the advanced syringes market?

The rise of injectable therapies is influencing demand, the adoption of biologics, healthcare worker safety requirements, vaccination programs, and the increasing preference for prefilled and safety-engineered injection systems.

Access the Full Syringes Market Report

Get segment-level forecasts, regional estimates, competitive benchmarking, company profiles and downloadable Excel datasets.

Download Sample Request Customization
Access the full Syringes Market Report
350 pages PDF & Excel | 2026-08-04
Download Sample Customization